Author

Y. El Laithy

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

B. K. van der Veer· 1 shared D. Annibali· 1 shared E. E. Cortesi· 1 shared F. Amant· 1 shared F. Lluis· 1 shared J.-J. Ventura· 1 shared K. P. Koh· 1 shared M. F. Baietti· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B. K. van der Veer

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Wnt/β-catenin inhibition disrupts drug-tolerance in isogenic carboplatin-resistant models of Triple-Negative Breast Cancer.

W. A. Abreu de Oliveira, S. Moens, Y. El Laithy, B. K. van der Veer, P. Athanasouli, E. E. Cortesi, M. F. Baietti, K. P. Koh, J.-J. Ventura, F. Amant, D. Annibali, F. Lluis

This study shows that inhibiting Wnt/β-catenin signaling resensitizes carboplatin-resistant TNBC models to chemotherapy, suggesting a synergistic therapeutic strategy.

bioRxiv · May 21, 2021Cancer Biology